Breastfeeding during the COVID-19 pandemic: Suggestions on behalf of woman study group of AMD.

Experimental Medicine Department, Sant'Andrea Hospital, "Sapienza" University of Rome, Italy. Electronic address: chiara.giul@gmail.com. S.S.D. di Endocrinologia e Malattie del Ricambio, "ASFO" Pordenone, Italy. Diabetology and Metabolic Diseases Unit, ULSS 8 Vicenza, Italy. Metabolism and Diabetes Unit, ASL TO4 Chivasso, TO, Italy. Department of Clinical and Experimental Medicine, University of Messina, Italy. Endocrinology, Diabetes, Metabolism and Clinical Nutrition, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy. Rete Clinica di Diabetologia Aziendale, Dipartimento Internistico di Ravenna, A.Usl della Romagna, Italy. Clinical and Molecular Medicine Department, Sant'Andrea Hospital, "Sapienza" University of Rome, Italy.

Diabetes research and clinical practice. 2020;:108239

Abstract

SARS-Cov2 infection has recently spread to Italy with important consequences on pregnancy management, mother and child health and mother-child contact. Breastfeeding improves the health of mother and child and reduces risk of neonatal infection with other pathogens that are likely to cause serious illness. To date no evidence confirmed COVID-19 vertical transmission from infected pregnant mother to their fetus. However it is well known that an infected mother can transmit the COVID-19 virus through respiratory droplets during breastfeeding or intimate contact. Thus, the mothers with known or suspected COVID-19 should adhere to standard and contact precautions during breastfeeding. Woman Study Group of AMD, after reviewing current knowledge about COVID-19 vertical transmission and the compatibility of breastfeeding in COVID-19 mother, the available recommendations from Health Care Organizations and main experts opinions, issued the following suggestions on breastfeeding during the COVID-19 pandemic, addressed both to mothers with and without diabetes. It should be considered that following suggestions may change in the future when more evidence is acquired regarding SARS-Cov2 infection.